ArticleFrontiers in bioengineering and biotechnology2026
A novel chitosan-collagen bilayer scaffold prevents contraction and accelerates cutaneous repair in a rat splint-skin model.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The treatment of chronic wound is extremely challenging and is often exacerbated by inflammation, poor angiogenesis and recurrent bacterial infections. To address this, we have developed a novel biomimetic bilayer three-dimensional scaffold with a chitosan-collagen upper epidermal layer, on top of a porous collagen-glycosaminoglycan dermal layer. Methods: In this study we assess this scaffold's efficacy in a preclinical wound model. In addition, we examined the scaffold with the addition of plasmid DNA encoding pro-angiogenic stromal derived factor-1α (SDF-1α) and anti-fibrotic β-klotho in a splinted full-thickness skin wound model on young Sprague Dawley rats for 14 days. Results: All the scaffold groups showed uniform deposition of extracellular matrix and showed no signs of wound contraction unlike our 'empty' defect group. Both the 'bilayer chitosan- collagen' group and 'gene activated group' showed that the upper chitosan layer was filled with exudate, which dried over time and formed a protective scab that delaminated easily at day 14. Our Chitosan- collagen scaffolds showed a decrease in pro-inflammatory IL-1β, an increase in the pro-angiogenic CD31 and a decrease in pro-fibrotic α-SMA protein expression. We showed enhanced pro-angiogenic and reduced pro-fibrotic expression with the addition of SDF and Klotho plasmids respectively (p < 0.01); however, the rate of wound healing was reduced with gene activation. Discussion: While the chitosan layer of the bilayer scaffold does not integrate into the wound bed it does form a protective covering with enhanced anti-inflammatory cues that support the lower integrating dermal collagen layer yielding optimal anti-fibrotic wound healing. These properties highlight the potential of this chitosan-collagen bi-layered scaffold, suggesting its suitability for promoting enhanced healing of chronic wounds in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.